410 related articles for article (PubMed ID: 25088603)
1. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
2. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
Cully M; You H; Levine AJ; Mak TW
Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
[TBL] [Abstract][Full Text] [Related]
3. PI(3)king apart PTEN's role in cancer.
Zhang S; Yu D
Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
[TBL] [Abstract][Full Text] [Related]
4. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
Wang X; Huang H; Young KH
Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
[TBL] [Abstract][Full Text] [Related]
5. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF
Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732
[TBL] [Abstract][Full Text] [Related]
6. PI3K/PTEN signaling in tumorigenesis and angiogenesis.
Jiang BH; Liu LZ
Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232
[TBL] [Abstract][Full Text] [Related]
7. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
8. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.
Xi Y; Chen Y
J Cell Biochem; 2015 Sep; 116(9):1837-47. PubMed ID: 25773992
[TBL] [Abstract][Full Text] [Related]
11. PTEN and the PI3-kinase pathway in cancer.
Chalhoub N; Baker SJ
Annu Rev Pathol; 2009; 4():127-50. PubMed ID: 18767981
[TBL] [Abstract][Full Text] [Related]
12. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational Regulation and Conformational Plasticity of PTEN.
Kotelevets L; Trifault B; Chastre E; Scott MGH
Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31932468
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.
Hopkins BD; Parsons RE
Clin Cancer Res; 2014 Nov; 20(21):5379-83. PubMed ID: 25361917
[TBL] [Abstract][Full Text] [Related]
16. PTEN and leukemia stem cells.
Fragoso R; Barata JT
Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
[TBL] [Abstract][Full Text] [Related]
17. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
18. Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia.
Langlois MJ; Roy SA; Auclair BA; Jones C; Boudreau F; Carrier JC; Rivard N; Perreault N
FASEB J; 2009 Jun; 23(6):1835-44. PubMed ID: 19168705
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
[TBL] [Abstract][Full Text] [Related]
20. PTEN mutation: many birds with one stone in tumorigenesis.
Liu W; Zhou Y; Reske SN; Shen C
Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
